<:||261 BIOLOGICAL DEVELOPMENT LOGS||:>

[Statua]

CITY 45 SHIELD BIOLOGICAL DEVELOPMENT
...Displaying Data...
CLASSIFIED INFORMATION
(/ooc you can only ICly read this if you have IC auths)

UNIT: 261
ACCESS LEVEL: 01
LOG ENTRIES: 3

BIOLOGICAL DEVELOPMENT PROJECTS DISPLAYS AS FOLLOWS
PROJECT
DATE
PROCEDURE
TESTING
REPORT
FUTURE USE
PROJECT STATUS

[Statua]

PROJECT: Dimethyl Monopotassium Phosphate (Blacksun)

DATE: 02.03.16

PROCEDURE: PREPARED 3 SOLUTIONS AT 1 2 AND 3 MOLAR CONCENTRATIONS

TESTING: TESTED IN THE ORDER OF 3 MOLAR, 2 MOLAR, AND 1 MOLAR

REPORT:
TEST RESULTS:
UPON TESTING THE 3 MOLAR, TEST SUBJECT RECEIVED ANTICIPATED HALLUCINATIONS. HOWEVER, AFTER 2MINUTES, THE TEST SUBJECT FELL INTO MYOCARDIAL INFARCTION. PREPARED VACCINE WAS APPLIED. SYMPTOMS AND MOYCARDIAL INFARCTION DISAPPEARED. HOWEVER AFTER APPROXIMATELY 30 SECONDS, TEST SUBJECTS BP DROPPED BELOW NORMAL, RESULTING IN DEATH.

CONCLUSION:
3 MOLAR MAY BE TOO STRONG. WILL TEST 2 MOLAR. VACCINE CAUSES LOSS IN BLOOD PRESSURE. REBUILDING CHEMICAL COMPOUND.

FUTURE USE: INTENDED FOR INTERROGATION USE
PROJECT STATUS: IN ALPHA TESTING PHASE

[Statua]

PROJECT: Dimethyl Monopotassium Phosphate (Blacksun)

DATE: 04.03.16

PROCEDURE: PREPARED THREE SOLUTIONS AT 1 2 AND 3 MOLAR CONCENTRATIONS. PREPARED NEW ANTIDOTE.

TESTING: TESTED IN THE ORDER OF 1 MOLAR, 2 MOLAR, AND 3 MOLAR

REPORT:
TEST RESULTS:
UPON TESTING 1 MOLAR, NO SYMPTOMS WERE FOUND AFTER 60 SECONDS. ANTIDOTE WAS ADMINISTERED, TEST SUBJECT REMAINED NORMAL THROUGHOUT. UPON TESTING 2 MOLAR, SUBJECT SHOWED SIGNS OF DISCOMFORT. AFTER 10 SECONDS, SUBJECT BEGAN CONVULSING. BEFORE THE ANTIDOTE COULD BE ADMINISTERED, SUBJECT FLAT LINED. SUBJECTS SKIN WAS NOTED TO BE VERY HOT TO THE TOUCH.

CONCLUSION:
1 MOLAR WAS TOO WEAK AND 2 MOLAR CAUSED IMPROPER SYMPTOMES. COMPOUND WILL BE REVISED. ANTIDOTE COMPOUND CONFIRMED SUCCESSFUL.

FUTURE USE: INTENDED FOR INTERROGATION USE
PROJECT STATUS: IN ALPHA TESTING PHASE

[Statua]

PROJECT: Dimethyl Monopotassium Phosphate (Blacksun)

DATE: 22.03.16

PROCEDURE: TESTED 2 REVISED SOLUTIONS AT 2 MOLAR AND 2.5 MOLAR WITH SALINE SOLUTION AND NEURON SOLUTION. ALSO TESTED THIRD SOLUTION AT 3 MOLAR WITH 0.1 MOLAR HYDROCHLORIC ACID ADDED. NO TEST SUBJECT USED

TESTING: TESTED IN THE ORDER OF 2 MOLAR, 2.5 MOLAR, AND 3 MOLAR WITH HCl

REPORT:
TEST RESULTS:
2 MOLAR INITIATED BLACKSUN SYMPTOMS BUT ONLY LASTED 10.4 SECONDS. 2.5 MOLAR INITIATES BLACKMOON SYMPTOMS FOR 8 MINUTES 44.3 SECONDS. 3 MOLAR WITH HCl REACTED VIOLENTLY WITH NEURON SOLUTION CREATING A FOAMING ACID REACTION WHICH DISINTEGRATED A RUBBER GLOVE WITHIN 15 SECONDS. NO INJURIES TO REPORT.

CONCLUSION:
2 MOLAR WAS TOO WEAK. 2.5 MOLAR MAY WORK BUT WILL LAST 8 MINUTES. 3 MOLAR WITH HCl REACTS VIOLENTLY AND IMPROPERLY.

FUTURE USE: INTENDED FOR INTERROGATION USE
PROJECT STATUS: IN ALPHA TESTING PHASE

[Statua]

PROJECT: Dimethyl Monopotassium Phosphate (Blacksun)

DATE: 26.03.16

PROCEDURE: TESTED BLACKSUN SOLUTION ON TEST SUBJECT ANTI-CITIZEN

TESTING: TESTED IN ORDER OF 2 MOLAR AND 2.5 MOLAR

REPORT:
TEST RESULTS:
2 MOLAR WORKED AS PREDICTED. SYMPTOMS OCCURRED SHORTLY AFTER INJECTION AND LASTED APPROXIMATELY 30 SECONDS. IN THE 30 SECOND TIME, TEST SUBJECT EXPERIENCED FRIGHTENING HALLUCINATIONS AS WELL AS ENHANCED LIGHT EXPOSURE TO THE EYES. TEST SUBJECT ANSWERED ALL QUESTIONS ASKED PROMPTLY.

2.5 MOLAR ALSO WORKED AS PREDICTED BUT LASTED 15 MINUTES RATHER THEN THE ESTIMATED 11. IT ALSO TOOK APPROX 15 SECONDS TO BEGIN REACTING WITH THE NEURONS RATHER THEN THE ALMOST  INSTANT RESPONSE FROM THE 2 MOLAR. SUBJECT ALSO CLAIMED TO HAVE HEARD SOUNDS AS IF THEY WERE ELECTRONIC AND HOLLOW. TEST SUBJECT ANSWERED ALL QUESTIONS INSTANTLY, ALMOST SPITTING THEM OUT WITHOUT BEING ASKED.

CONCLUSION:
2.5 MOLAR WOULD BE AN EXCELLENT ASSET TO INTERROGATIONS. 2.5 MOLAR WILL BE MOVED FROM ALPHA TESTING PHASE TO BETA TESTING PHASE.

FUTURE USE: INTENDED FOR INTERROGATION USE
PROJECT STATUS: IN BETA TESTING PHASE

[Statua]

PROJECT: Dimethyl Monopotassium Phosphate (Blacksun)

DATE: 01.04.16

PROCEDURE: PERIODIC TESTING OF BLACKSUN ON SELECT SUBJECTS. TESTED IN REAL INTERROGATIONS.

TESTING: TESTED ON 5 SUBJECTS AND 3 INTERROGATION SUBJECTS

REPORT:
TEST RESULTS:
NO NEGATIVE EFFECTS WERE NOTED DURING TESTING. BLACKSUN WORKS FOR A PERIOD OF EIGHT MINUTES AND THIRTY SECONDS ON AVERAGE, PLUS OR MINUS THIRTY SECONDS. ALL 5 SUBJECTS EXPERIENCED SYMPTOMS, FEMALES MORE THEN MALES. THREE INTERROGATION SUBJECTS GAVE INFORMATION OUT AT A HIGHER AND MORE COMPLIANT RATE, ESPECIALLY IF PROVIDED THE OPTION TO BE GIVEN THE ANTIDOTE AFTER PROVIDING INFORMATION.

CONCLUSION:
BLACKSUN IS SUCCESSFUL AND READY FO USE ON THE FIELD

FUTURE USE: INTENDED FOR INTERROGATION USE
PROJECT STATUS: COMPLETE

[Statua]

PROJECT: Automated External Defibrillator

DATE: 09.04.16

PROCEDURE: CONSTRUCTION AND DUMMY TESTING OF AED.

TESTING: TESTED WITH ELECTRICAL DUMMY THAT EMITS ELECTRICAL PULSES, SIMILAR TO THE HEART.

REPORT:
TEST RESULTS:
AFTER A FEW CHIP MODIFICATIONS, THE DEVICE CAN DETECT AN IRREGULAR HEARTBEAT, NO HEARTBEAT, AND A REGULAR HEARTBEAT. DEVICE DISCHARGES AT CORRECT VOLTAGE ACCORDING TO CONDITIONS.

CONCLUSION:
DEVICE IS READY FOR TESTING IN SUBJECTS.

FUTURE USE: INTENDED FOR EMERGENCY DEFIBRILLATION ON THE FIELD, TO BE DISTRIBUTED TO EVERY SINGLE UNIT.
PROJECT STATUS: TESTING

[Statua]

PROJECT: Automated External Defibrillator

DATE: 13.04.16

PROCEDURE: ALPHA TEST OF AED.

TESTING: TESTED WITH LIVE SUBJECTS WHO WERE GIVEN A POISON TO INVOKE HEART FIBRILLATION.

REPORT:
TEST RESULTS:
RESULTS RETURNED POSITIVE. 4 OF 5 SUBJECTS SURVIVED, 3 OF WHICH SUSTAINED NO BRAIN DAMAGE.

CONCLUSION:
DEVICE IS READY FOR BETA TESTING IN THE FIELD. WILL BE PROGRAMMING A COMM VOICE OVER WHICH WILL GIVE STEP BY STEP INSTRUCTIONS IN PLAIN CLEAR ENGLISH TO THE OWNER OF THE AED VIA COMM.

FUTURE USE: INTENDED FOR EMERGENCY DEFIBRILLATION ON THE FIELD, TO BE DISTRIBUTED TO EVERY SINGLE UNIT.
PROJECT STATUS: BETA TESTING

[Globey]

///it a croot tosses it into the furnace... again

[Statua]

PROJECT: Autonomous Xeno Controller

DATE: 08.07.16

PROCEDURE: ALPHA TESTING XENO CONTROLLER.

TESTING: COMMANDED XENO SPECIMEN  TO TRAVEL THE HALLS OF THE NEXUS UNDER CAREFUL MONITORING.

REPORT:
TEST RESULTS:
RESULTS RETURNED POSITIVE. XENO SPECIMEN FOLLOWED COMMANDS PERFECTLY AND DID NOT ACT AGGRESSIVE EXCEPT FOR A GROWL AT 087.

CONCLUSION:
MORE COMMANDS WILL BE IMPLEMENTED SUCH AS ATTACKS, FOLLOWING, AND HIDING/WATCHING.

FUTURE USE: INTENDED FOR INFILTRATION OF RESISTANCE HOT SPOTS TO GATHER INTEL.
PROJECT STATUS: ALPHA TESTING

[swag master spiderman]

// you got my digits wrong (087)

still that freaked me out

[Statua]

PROJECT: Autonomous Xeno Controller

DATE: 30.07.16

PROCEDURE: ALPHA TESTING XENO CONTROLLER AFTER AUGMENTING WITH SUCTION/HOOK PADS, INTERNAL CAMERA, AND NEURO ENHANCERS. UPDATED SOFTWARE.

TESTING: COMMANDED XENO SPECIMEN  TO TRAVEL THE HALLS OF THE NEXUS UNDER CAREFUL MONITORING.

REPORT:
TEST RESULTS:
RESULTS RETURNED POSITIVE. XENO SPECIMEN FOLLOWED ORDERS AS GIVEN AND NAVIGATED AUTONOMOUSLY WITH PROVIDED AREA MAP. TESTED SOME SPECIFIC FUNCTIONS SUCH AS INVERTED MOVEMENT AND MEMORY TRACKING. SUBJECT STILL SHOWS SIGNS OF PERSONALITY. WAS UNABLE TO TEST ATTACKS, FOLLOWING, AND HIDING/WATCHING. POWER SUPPLY DIDN'T LAST LONG ENOUGH.

CONCLUSION:
WILL WORK ON AUTONOMOUS NAVIGATION AND A LONGER LASTING POWER SUPPLY.

FUTURE USE: INTENDED FOR INFILTRATION OF RESISTANCE HOT SPOTS TO GATHER INTEL.
PROJECT STATUS: ALPHA TESTING

[smt]

// i know its for "added ic effect" but the caps are really raping my eyes, fun to read either way

[Nuka-Cola ?ã??à²?ç??à²??]

Nice Logs Very interesting to read keep them up!.

[Statua]

PROJECT: Automated External Defibrillator

DATE: 30.07.16

PROCEDURE: END OF BETA TEST.

TESTING: TESTED AED ON FIELD DURING REAL EMERGENCY SITUATIONS.

REPORT:
TEST RESULTS:
AED PERFORMED PERFECTLY. ONLE 2 OF 11 PATIENTS WHO REQUIRED THE AED WERE NOT REVIVED. AED SOFTWARE WORKED PERFECTLY WITH NO GLITCHES. AFTER GIVING ANOTHER UNIT THE AED, HE HAD NO PROBLEMS USING THE DEVICE.

CONCLUSION:
DEVICE IS READY FOR DISTRIBUTION. IT IS EXPECTED TO INCREASE THE SURVIVAL RATE OF CARDIAC ARREST PATIENTS BY 80%.

FUTURE USE: INTENDED FOR EMERGENCY DEFIBRILLATION ON THE FIELD, TO BE DISTRIBUTED TO EVERY SINGLE UNIT.
PROJECT STATUS: COMPLETE